A detailed history of Garrison Point Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Garrison Point Advisors, LLC holds 1,635 shares of ABBV stock, worth $272,260. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,635
Previous 1,535 6.51%
Holding current value
$272,260
Previous $237,000 25.32%
% of portfolio
0.19%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $15,982 - $18,210
100 Added 6.51%
1,635 $297,000
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $221,976 - $255,638
1,535 New
1,535 $244,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Garrison Point Advisors, LLC Portfolio

Follow Garrison Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Point Advisors, LLC with notifications on news.